INTELGENX TECHNOLOGIES CORP. (IGXT)

Company Overview
IntelGenx Technologies Corp. engages in the development of oral controlled-release products both for the branded and generic pharmaceutical market as well as novel oral drug delivery systems. Its product portfolio comprises of drug candidates for the treatment of coronary heart failure and hypertension and other indications; for smoking cessation, osteoarthritis as well as antidepressants, vitamin supplements, etc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
read more

Watch the video to learn about the probability of INTELGENX TECHNOLOGIES CORP. (IGXT) Chart Signal as of Oct 25, 2014

Hotstocked Precision will calculate the probabilities of INTELGENX TECHNOLOGIES CORP. (IGXT)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 09:03PM EDT October 25, 2014
$ 0.386   -0.02 (-3.98%)
Today's Open: 0.402 Previous Close: 0.402
Today's High: 0.4064 Volume: 221,362
Today's Low: 0.386 Avg Vol: 197,009
52 Week High: 1.18 Bid (size): 0
52 Week Low: 0.3702 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 6425 Abrams, Ville Saint Laurent, QC H4S 1X9, Canada
Mailing Address: -
Phone: 514-331-7440
Fax: 514-331-0436
Website: http//www.intelgenx.com

Company Details:

Symbol: IGXT
SIC: -
State location: A8
Sector: -
State of Inc: DE
Employees: 10
Type: -

Key executives:

Name Age Position

Watch the video to learn about the probability of INTELGENX TECHNOLOGIES CORP. (IGXT) Chart Signal as of Oct 25, 2014

This free program will calculate the probabilities of INTELGENX TECHNOLOGIES CORP. (IGXT) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

IntelGenx Technologies Corp. (OTC:IGXT) Stable at the Current Level November 24, 2011

After the end of yesterday's trading session the stock price of IntelGenx Technologies Corp. (OTC:IGXT) looks stable at its current level. Unfortunately, even the announced FDA approval could not move IGXT share price for more than a day. read more

IntelGenx Technologies Corp. (OTC:IGXT) Expects FDA Decision Today November 10, 2011

Over three consecutive trading sessions the share price of IntelGenx Technologies Corp. (OTC:IGXT) is falling down again. Today's session might be crucial as the market expects news from the FDA related to the approval of IGXT lead drug candidate. read more

IntelGenx Technologies Corp. (OTC:IGXT) Touched the 50-Day Moving Average October 31, 2011

On Friday the share price of IntelGenx Technologies Corp. (OTC:IGXT) rose to the 50-day moving average without any news from the company. Yesterday evening, we received a promotional newsletter on the stock and it seems like traders are expecting FDA de... read more

IntelGenx Technologies Corp. (OTC:IGXT) Falls Down Again After CEO Presentation September 16, 2011

A day after IntelGenx Technologies Corp. (OTC:IGXT) corporate presentation, the share price of the company gapped down at market open yesterday. There was no particular reason for the lower closing price, apart from the still missing CEO presentation th... read more

LATEST STOCK PROMOTIONS

IGXT Mid Day Alert. The climb continues Nov 01, 2011, 11:36

  MID-DAY ALERT IGXT ....and the power continues today..waiting on FDA announcement       FDA Decision Date: November 13, 2011Drug to be approved: CPI-300 Market Potential: $300 million a year     Upcoming Milestones 2011 2011 FDA Approval CPI300 CPI300 Commercial Launch Two/Three New Licensing Deals2012 Two New Licensing Deals Two Regulatory Submissions INT0010 read more

Promoter: NYC Marketing inc Paying Party: UNKNOWN Max Profit: 9.26% Gain at close: 9.26%
Stock: IGXT Compensation: $26,000 Avg $ Volume for Period: 1,131,520

IGXT waiting on FDA announcement Oct 30, 2011, 21:18

  Announcing... IGXT waiting on FDA announcement       FDA Decision Date: November 13, 2011Drug to be approved: CPI-300 Market Potential: $300 million a year     Upcoming Milestones 2011 2011 FDA Approval CPI300 CPI300 Commercial Launch Two/Three New Licensing Deals2012 Two New Licensing Deals Two Regulatory Submissions INT0010 Successful Phase II/III2013 Launch read more

Promoter: NYC Marketing inc Paying Party: UNKNOWN Max Profit: 9.09% Gain at close: 8.93%
Stock: IGXT Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

INTELGENX TECHNOLOGS (IGXT) MESSAGE BOARD

Post # Subject Re Name Date
1 You better look at the "webcast" of the... 0
2 Is there a webcast available of Dr. Horst... 1
3 Any news from IGXT and the Annual J.P.... 0
4 IMO, last week when was disseminated the... 0
5 So what may be expected now? Can IGXT... 0
6 Looks, you are not in the group of... 1
7 Why do you think so? There is no a... 1
8 Why the trading activity on IGXT is so weak? 1
9 Can you be more precise e.brainy? Do you... 1
10 One of reasons? Bedford had a paid press... 1
11 Still at the bottom?! 0
12 Continues to fall down?! 0
13 What the hell, was the reason to see IGXT... 2
14 IntelGenx is developing oral... 1
15 What IntelGenx engages in?Any ideas? 1
16 Here on this message board we are inviting... 0